These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16120376)
1. Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies. McComsey GA; Walker UA Mitochondrion; 2004 Jul; 4(2-3):111-8. PubMed ID: 16120376 [TBL] [Abstract][Full Text] [Related]
2. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Nolan D; Hammond E; James I; McKinnon E; Mallal S Antivir Ther; 2003 Dec; 8(6):617-26. PubMed ID: 14760896 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Gerschenson M; Shiramizu B; LiButti DE; Shikuma CM Antivir Ther; 2005; 10 Suppl 2():M83-9. PubMed ID: 16152709 [TBL] [Abstract][Full Text] [Related]
4. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells. Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828 [TBL] [Abstract][Full Text] [Related]
6. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity. Walker UA; Venhoff N Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713 [TBL] [Abstract][Full Text] [Related]
7. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions. Walker UA; Auclair M; Lebrecht D; Kornprobst M; Capeau J; Caron M Antivir Ther; 2006; 11(1):25-34. PubMed ID: 16518957 [TBL] [Abstract][Full Text] [Related]
8. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. Mallon PW; Unemori P; Sedwell R; Morey A; Rafferty M; Williams K; Chisholm D; Samaras K; Emery S; Kelleher A; Cooper DA; Carr A; J Infect Dis; 2005 May; 191(10):1686-96. PubMed ID: 15838796 [TBL] [Abstract][Full Text] [Related]
9. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy. Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254 [TBL] [Abstract][Full Text] [Related]
10. Adipocyte dysfunction in response to antiretroviral therapy: clinical, tissue and in-vitro studies. Caron M; Vigouroux C; Bastard JP; Capeau J Curr Opin HIV AIDS; 2007 Jul; 2(4):268-73. PubMed ID: 19372898 [TBL] [Abstract][Full Text] [Related]
11. Long-term complications of antiretroviral therapy: lipoatrophy. Waters L; Nelson M Int J Clin Pract; 2007 Jun; 61(6):999-1014. PubMed ID: 17504362 [TBL] [Abstract][Full Text] [Related]
12. Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy. Lewis W Mitochondrion; 2004 Jul; 4(2-3):141-52. PubMed ID: 16120379 [TBL] [Abstract][Full Text] [Related]
13. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821 [TBL] [Abstract][Full Text] [Related]
14. HIV and mitochondrial toxicity in children. Foster C; Lyall H J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978 [TBL] [Abstract][Full Text] [Related]
15. Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues. Caron M; Auclairt M; Vissian A; Vigouroux C; Capeau J Antivir Ther; 2008; 13(1):27-38. PubMed ID: 18389896 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Velsor LW; Kovacevic M; Goldstein M; Leitner HM; Lewis W; Day BJ Toxicol Appl Pharmacol; 2004 Aug; 199(1):10-9. PubMed ID: 15289086 [TBL] [Abstract][Full Text] [Related]
18. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial. Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H Antivir Ther; 2007; 12(1):97-105. PubMed ID: 17503753 [TBL] [Abstract][Full Text] [Related]
19. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Lewis W Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]